Lebanon has approved the urgent use of Sinopharm China Biological New Crown vaccine!

According to Naharnet, a news agency in Lebanon, on March 1 local time, a scientific committee set up by Hamad Hassan, Minister of health of the caretaker government of Lebanon, approved the emergency use license of Sinopharm China biocrown inactivated vaccine

.

At the request of Lebanon, China has decided to provide assistance to Lebanon for China National Pharmaceutical Group’s bio novel coronavirus inactivated vaccine to help prevent and control the epidemic in Lebanon, CCTV News reported Tuesday

.

Up to now, the two new coronal inactivated vaccines developed by Sinopharm Beijing Institute of biological products and Wuhan Institute of biological products have been approved for conditional marketing in China on December 30, 2020 and February 25, 2021 respectively, with more than 44 million people vaccinated at home and abroad

.

Sinopharm sinobio’s novel coronavirus vaccine has been approved and registered in the United Arab Emirates, Bahrain, Bolivia and Seychelles on December 9 and 13, 2020 and February 5 and 25, 2021, respectively, and has been inoculated or used urgently in more than 30 countries and regions around the world

.

The technical safety, protection effectiveness, population universality, production capacity accessibility and convenient storage and transportation of the vaccine have been improved It is highly recognized by the international community

.

China is actively participating in who’s novel coronavirus vaccine implementation plan and has decided to provide 10 million doses of vaccine to meet the urgent needs of developing countries

.

China has also decided to participate in the group of friends of new vaccines for peacekeepers and donate vaccines to UN peacekeepers

.

Source: China biological declaration: This article is

.